1117-AB83 202504 Unified Agenda of Federal Regulatory and Deregulatory Actions 1117 Drug Enforcement Administration DEA 1100 Department of Justice DOJ Medical Marijuana and Cannabidiol Research Expansion

Pursuant to Public Law 117-215, Medical Marijuana and Cannabidiol Research Expansion Act, passed on December 2, 2022, DEA plans on modifying its regulations related to the new application process and submission of supporting materials by electronic means only, through the Diversion Control Division secure online portal, for those who are manufacturing marijuana or cannabidiol for medical research and those who are conducting medical marijuana and cannabidiol research.

]]> Other Significant Previously Published in The Unified Agenda Completed Actions No No Other 21 CFR 1301 Pub. L. 117-215 No Withdrawn 04/21/2025 Docket Number DEA-1132 No None No No DPW@dea.gov www.regulations.gov No No Heather Achbach E Acting Section Chief, Regulatory Drafting and Support Section 1117 Drug Enforcement Administration DEA 571 387-3185 heather.e.achbach@dea.gov Diversion Control Division, 8701 Morrissette Drive, Springfield VA 22152